Abstract | BACKGROUND: AIMS: METHODS: The nudemousemodel of hypertrophic scar was created and subjected to daily injections with ASODN and LipofectamineTM for 2 ,4 or 6 weeks.We then examined the scars for changes in histopathological characteristics. The effects of ASODNon type I collagen gene expression were examined by reverse transcription-polymerase chain reaction and Western blots. RESULTS: The ASODN could remarkably alleviate the scar in the nude mouse model and consistently inhibit type I collagen gene expression at both the mRNA and protein levels. CONCLUSION: ASODN was effective in downregulating type I collagen gene expression and could prove to be useful in the treatment of scars.
|
Authors | Julin Xie, Shaohai Qi, Jishan Yuan, Yinbing Xu, Tianzeng Li, Houdong Li, Xusheng Liu, Bin Shu, Huizeng Liang |
Journal | Journal of cutaneous pathology
(J Cutan Pathol)
Vol. 36
Issue 11
Pg. 1146-50
(Nov 2009)
ISSN: 1600-0560 [Electronic] United States |
PMID | 19469869
(Publication Type: Journal Article)
|
Chemical References |
- Collagen Type I
- Oligodeoxyribonucleotides, Antisense
|
Topics |
- Animals
- Blotting, Western
- Cicatrix, Hypertrophic
(genetics, prevention & control)
- Collagen Type I
(genetics)
- Down-Regulation
- Enzyme-Linked Immunosorbent Assay
- Gene Expression
(drug effects)
- Humans
- Mice
- Mice, Nude
- Oligodeoxyribonucleotides, Antisense
(pharmacology)
- Reverse Transcriptase Polymerase Chain Reaction
- Skin Transplantation
|